However, it was not until recently that a similar pattern was established for alterations in NF1, with a cohort study finding a two-fold increased risk for women with NF1 compared to women without hereditary breast cancer-related mutations, though this risk was still half that of women with BRCA1/2 mutations [17]. The gene discussed is NF1; the disease is breast carcinoma.